
Lonza Group AG
LONN · SW · Healthcare / Diagnostics & Research
Price History
Full chartMarket Stats
About
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Company Details
- SectorHealthcare
- IndustryDiagnostics & Research
- CEODr. Wolfgang Wienand Ph.D.
- Employees20.14K
- HeadquartersMuenchensteinerstrasse 38, Basel, Switzerland, 4002, Switzerland
- Websitehttps://www.lonza.com
Leadership
- Dr. Wolfgang Wienand Ph.D.Chief Executive Officer · b. 1972
- Mr. Philippe DeeckeChief Financial Officer
- Mr. Jason BerndtExecutive VP & Head of Group Operations
- Mr. Daniel BuchtaHead of Investor Relations
- Mr. Andreas BohrerChief Legal & Corporate Affairs Officer
- Ms. Kim HarrelsonHead of Ethics & Compliance, ERM and Corporate Responsibility
- Mr. Hans TreesSenior VP & Global Head of Communications
- Ms. Jennifer ClancySenior Director of Global Marketing
- Ms. Nicoleta BaumgartnerChief Human Resources Officer · b. 1971
- Dr. Matthias HofmannHead of Corporate Environment, Health, Safety & Global Sustainability
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Dividends
Stock Splits
- May 2, 2017407:377
- Apr 3, 200210:1